Patriot News Organization

Source: Read Full Article

In a recent study published in Environmental Research, researchers examined the effects of prenatal exposure to chemicals on early child language ability. Study: The association of prenatal phthalates, organophosphate pesticides, and organophosphate esters with early child language ability in Norway….

SEOUL (Reuters) – Tens of thousands of North Koreans and people in South Korea, Japan and China could be exposed to radioactive materials spread through groundwater from an underground nuclear test site, a Seoul-based human rights group said in a…

Comedian Hayley Morris has lived with intrusive thoughts for as long as she can remember. It was an experience she was ashamed of until she began sharing it with her social media following. Content note: this article contains references to…

Supported by a new $3.14 million grant from the National Institutes of Health to Cleveland Clinic, researchers are using an emerging technology known as "digital twins" to better understand healthcare disparities based on where someone lives. Researchers from Cleveland Clinic…

If you use Enfamil ProSobee Simply Plant Based Infant Formula for your baby, go check the label; Reckitt, one of the United States’ biggest formula manufacturers, issued a recall of some of its product on February 20th. Don’t panic, though…

An international team of medical scientists has found more evidence of infections in pregnant women raising the risk of leukemia developing in babies. In their paper published in JAMA Network Open, the group analyzed data from several Danish medical registries…

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Approximately one in four patients with untreated COVID-19 experience symptom relapse, while almost one in three exhibits relapse of viral load, a recent study finds. These…

A low, but anticipated threat Monitoring the risks of animal viruses Source: Read Full Article

PARIS — Two tyrosine kinase inhibitors (TKI) used in the treatment of chronic myeloid leukemia (CML) — nilotinib (Tasigna) and ponatinib (Iclusig) — may cause atherosclerotic arterial diseases. This common side effect, which has even been seen in patients without cardiovascular risk factors, has gone unnoticed in…